The Psychedelic Report Why Are We So Easily Deceived About Psychedelics? Featuring Hamilton Morris
Oct 21, 2024
01:09:15
Is our time quickly becoming the era of “psychedelic McCarthyism”? If we’re not careful, that’s where it looks like we’re heading… In this episode of The Psychedelic Report, Dr. Dave Rabin sits down with Hamilton Morris for an in-depth discussion on the recent controversy surrounding MDMA-assisted therapy and the FDA's pivotal August 9th decision. Together, they address the backlash against MAPS/Lykos and how misinformation has fueled public skepticism and prevented this safe and powerful treatment from getting to millions of patients suffering from PTSD.
Hamilton shares his experience from evaluation and investigation of the MDMA clinical trials and sheds light on the media's tendency to sensationalize allegations, including claims of misconduct during the trials. Hamilton and Dr Rabin emphasize the importance of relying on the scientific method, evidence-based data, and research, rather than sensationalized narratives, when assessing the safety and efficacy of MDMA-assisted therapy.
The conversation also explores the broader implications of the FDA's ruling and how the negative hype surrounding psychedelics has overshadowed their significant therapeutic benefits and is causing harm to patients in need. They call for a more balanced and responsible approach to discussing these therapies in both journalism and public discourse, advocating for truth and evidence over fear and speculation.
This episode offers critical insights into the challenges facing psychedelic research today, highlighting the need for thoughtful engagement with the ongoing developments in this field.
Hamilton shares his experience from evaluation and investigation of the MDMA clinical trials and sheds light on the media's tendency to sensationalize allegations, including claims of misconduct during the trials. Hamilton and Dr Rabin emphasize the importance of relying on the scientific method, evidence-based data, and research, rather than sensationalized narratives, when assessing the safety and efficacy of MDMA-assisted therapy.
The conversation also explores the broader implications of the FDA's ruling and how the negative hype surrounding psychedelics has overshadowed their significant therapeutic benefits and is causing harm to patients in need. They call for a more balanced and responsible approach to discussing these therapies in both journalism and public discourse, advocating for truth and evidence over fear and speculation.
This episode offers critical insights into the challenges facing psychedelic research today, highlighting the need for thoughtful engagement with the ongoing developments in this field.
- Instagram: https://www.instagram.com/hamiltonmorris/
- Hamilton’s Pharmacopeia: https://www.vicetv.com/en_us/show/hamiltons-pharmacopeia
- The Hamilton Morris Podcast: https://hamiltonmorris.buzzsprout.com/1870388
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/